|
Alexander E. Barkas Ph.D. has served as Chairman of the Board since July 1993 and as a director of the Company since March 1992. Dr. Barkas is a Managing Director of Prospect Venture Partners. Prior to co-founding Prospect Venture Partners I II and III Dr. Barkas was a Partner at Kleiner Perkins Caufield & Byers (KPCB) from 1991 to 1997 where he focused on health care product company investments in the drug device and diagnostic sectors. Prior to KPCB Dr. Barkas was a founder and CEO of BioBridge Associates a health care industry consulting firm from 1989 to 1991. From 1987 to 1989 he served as the Director of Technology Development at Advanced Biosearch Associates a regulatory affairs advisory firm where he focused on medical product commercialization and medical device regulatory strategy. Dr. Barkas' research experience was gained at Memorial Sloan Kettering Cancer Center the Genetics Department at the Toronto Hospital for Sick Children the Whitehead Institute at MIT and Duke University. Dr. Barkas is currently Chairman of the Board of Tercica and serves or has served on the Board of Directors of Amicus Archemix ChimeraCore Connetics (now Stiefel Laboratories Inc.) Complete Genomics Inc. NeoMend Novacept SurgRx Transave Verus Pharmaceuticals Zelos Therapeutics and several other privately held companies. Dr. Barkas received a Ph.D. in Biology from New York University and a B.A. in Biology from Brandeis University where he currently is Chairman of the University Science Advisory Council and serves on the Board of Trustees. | 